Concepedia

Patrick Burke

PB

Statistics

Publications

30

Citations

2.5K

H-Index

20

Active since

2000

Affiliations

Seagen (United States)(Current)

University of Colorado Boulder

Washington University in St. Louis

University of Colorado Denver

University of Colorado Cancer Center

Patrick Burke is an author at Seagen (United States) specializing in pharmacy, antibody conjugates, and antibody-drug conjugates.

ORCID

Publications per year

2000–2021

30

Publications

30

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index

Robert P. Lyon, Tim D. Bovee, Svetlana O. Doronina et al. · Nature Biotechnology · 2015 · 523 citations

, , +14

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey et al. · Blood · 2013 · 386 citations

, , +13

A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology

Scott C. Jeffrey, Patrick Burke, Robert P. Lyon et al. · Bioconjugate Chemistry · 2013 · 246 citations

, , +17

Development of orally active inhibitors of protein and cellular fucosylation

Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson et al. · Proceedings of the National Academy of Sciences · 2013 · 192 citations · Full text

, , +17

Formaldehyde in Human Cancer Cells:  Detection by Preconcentration-Chemical Ionization Mass Spectrometry

Shuji Kato, Patrick Burke, Tad H. Koch et al. · Analytical Chemistry · 2001 · 158 citations

, , +14

1–5 of 30